Kim Janda

Dr. Janda has been the Ely R. Callaway, Jr. Chaired Professor in the Departments of Chemistry, Immunology and Microbial Science at The Scripps Research Institute (TSRI) since 1996. Dr. Janda has been the Director of the Worm Institute of Research and Medicine (WIRM) at The Scripps Research Institute since 2005. He has served as an Associate Professor/Skaggs Scholar within the Skaggs Institute of Chemical Biology, also at The Scripps Research Institute, since 1996. Over a career of almost 25 years, Dr. Janda has provided numerous seminal contributions and is considered one of the first scientists to merge chemical and biological approaches into a cohesive research program. He has been a Director of Sorrento Therapeutics, Inc. since April 15, 2012. He serves as Member of Scientific Advisory Board of Medisyn Technologies, Inc. He serves on the Scientific Advisory Boards of Singapore Ministry of Education (“MOE”), EP1 Physical Sciences. He was a Scientific Advisor of Materia, Inc. He has published over 425 original publications in peer-reviewed journals and founded the biotechnological companies CombiChem, Drug Abuse Sciences, and AIPartia. Dr. Janda received B.S. degree in Clinical Chemistry from University of South Florida in 1980 and M.S. from University of Arizona in 1983. He holds Ph.D./doctoral degree from the University of Arizona with Robert B. Bates in natural product total synthesis in 1984.